Skip to main content

NLP streamlines clinical trial population selection

Tim O'Connell, CEO and founder of Emtelligent, talks about Emtelligent's NLP software, which is specially designed to understand medical English, and how it can assist drug companies with finding clinical trial cohorts from patient records.
By HIMSS TV
Tags: